安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Illumina | Sequencing and array solutions to fuel genomic discoveries
Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics
- Illumina, Inc. - Investors
A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments We are dedicated to improving human health by unlocking the power of the genome
- Illumina’s New CIO Brings R D Mindset As AI Transforms Genomics - Forbes
Illumina reported $4 3 billion in revenue for fiscal year 2024 In its most recent earnings report, the company lowered its full-year guidance and announced a $100 million cost reduction program
- Illumina Knowledge | Illumina Knowledge
Illumina Connected Software Illumina com Illumina Support More Illumina Knowledge; What's New; Announcements; Cloud Status; Instrumentation General iSeq 100 MiniSeq MiSeq MiSeq i100 Series NextSeq 500 550 NextSeq 1000 2000 cBot HiSeq 1000 2500 HiSeq X NovaSeq X X Plus NovaSeq 6000 Instrument Administration
- MyIllumina
MyIllumina provides a personalized dashboard for managing instrument runs, product orders, and support inquiries
- Illumina, Inc. (NASDAQ:ILMN) Receives Average . . . - MarketBeat
Illumina, Inc (NASDAQ:ILMN - Get Free Report) has earned a consensus rating of "Hold" from the nineteen research firms that are presently covering the company, Marketbeat Ratings reports One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company
- Genomics products | Illumina
Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications
- Infinity Bio Closes $8M Series A Financing Led by Illumina . . . - BioSpace
Illumina Ventures is an independently managed, healthcare-focused venture firm in a strategic partnership with Illumina (NASDAQ: ILMN) As an early-stage, value-add investor, Illumina Ventures helps entrepreneurs develop breakthrough science and technologies into market-leading companies to transform healthcare The firm focuses on investment
|
|
|